Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Mar;16(3):781-787.
doi: 10.1111/os.13956. Epub 2024 Jan 7.

Pay Attention to the Osteochondromas in Fibrodysplasia Ossificans Progressiva

Affiliations
Case Reports

Pay Attention to the Osteochondromas in Fibrodysplasia Ossificans Progressiva

Longqing Li et al. Orthop Surg. 2024 Mar.

Abstract

Background: Fibrodysplasia ossificans progressiva (FOP) is an extremely rare disease characterized by malformation of the bilateral great toes and progressive heterotopic ossification. The clinical features of FOP occur due to dysfunction of the bone morphogenetic protein (BMP) signaling pathway induced by the mutant activin A type I receptor/activin-like kinase-2 (ACVR1/ALK2) which contributes to the clinical features in FOP. Dysregulation of the BMP signaling pathway causes the development of osteochondroma. Poor awareness of the association between FOP and osteochondromas always results in misdiagnosis and unnecessary invasive operation.

Case presentation: In this study, we present a case of classical FOP involving osteochondroma. An 18-year-old male adolescent, born with deformity of bilateral big toes, complained multiple masses on his back for 1 year. The mass initially emerged with a tough texture and did not cause pain. It was misdiagnosed as an osteochondroma. After two surgeries, the masses became hard and spread around the entire back region. Meanwhile, extensive heterotopic ossification was observed around the back, neck, hip, knee, ribs, and mandible during follow-up. Osteochondromas were observed around the bilateral knees. No abnormalities were observed in the laboratory blood test results. Whole exome sequencing revealed missense mutation of ACVR1/ALK2 (c.617G > A; p.R206H) in the patient and confirmed the diagnosis of FOP.

Conclusion: In summary, classical FOP always behaves as a bilateral deformity of the big toes, as well as progressive ectopic ossification and osteochondromas in the distal femur and proximal tibia. An understanding of the association between osteochondromas and FOP aids in diagnosis and avoids unnecessary invasive management in patients.

Keywords: ACVR1/ALK2; Association; Bone Morphogenetic Protein; Fibrodysplasia Ossificans Progressiva; Osteochondromas.

PubMed Disclaimer

Conflict of interest statement

All named authors have no conflicts of interest to disclose in relation to this article.

Figures

FIGURE 1
FIGURE 1
Timeline of this disease.
FIGURE 2
FIGURE 2
(A) Multiple masses on the back (red arrow); (B) Bilateral valgus deformity of the great toes.
FIGURE 3
FIGURE 3
(A) Radiograph of the knee for consecutive 5 years demonstrated that the osteochondromas located at the bilateral distal femurs and proximal tibias kept constant in the morphology, volume and character. (B) Pathology of the mass revealed the osteochondromas with plenty of hyperplastic bone and cartilage.
FIGURE 4
FIGURE 4
Heterotopic ossifications. (A) The “armor‐like” ossification band on the back. (B) The heterotopic ossification of the right 8th rib and scoliosis to left. (C) and (D) The heterotopic ossification at bilateral hips and proximal humerus. (D‐H) The new formed heterotopic ossification at right thigh, bilateral knees, neck and the mandible after stopping taking the indomethacin. (I) The heterozygous mutation of the ACVR1 (c.617G>A; p.R206H) in this patient.

Similar articles

References

    1. Rocke DM, Zasloff M, Peeper J, Cohen RB, Kaplan FS. Age‐ and joint‐specific risk of initial heterotopic ossification in patients who have fibrodysplasia ossificans progressiva. Clin Orthop Relat Res. 1994;301:243–248. - PubMed
    1. Meyers C, Lisiecki J, Miller S, Levin A, Fayad L, Ding C, et al. Heterotopic ossification: a comprehensive review. JBMR Plus. 2019;3(4):e10172. - PMC - PubMed
    1. Kaplan FS, Le Merrer M, Glaser DL, Pignolo RJ, Goldsby RE, Kitterman JA, et al. Fibrodysplasia ossificans progressiva. Best Pract Res Clin Rheumatol. 2008;22(1):191–205. - PMC - PubMed
    1. Akesson LS, Savarirayan R. Fibrodysplasia Ossificans Progressiva [M]//Adam M P, Ardinger H H, Pagon R A, et al. GeneReviews (®). Seattle (WA): University of Washington, Seattle Copyright © 1993–2021, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved; 1993.
    1. Pignolo RJ, Shore EM, Kaplan FS. Fibrodysplasia Ossificans Progressiva: clinical and genetic aspects. Orphanet J Rare Dis. 2011;6(1):80. - PMC - PubMed

Publication types